Warren Buffett
Berkshire Hathaway
Warren Buffett Merck & Company Inc stake
total: 135
Berkshire Hathaway MRK trades
- Total transactions:
- 5
- New positions:
- 1
- Sold out:
- 1
- Added:
- 1
- Reduced:
- 2
- Held since:
- 2020 Q3
- Held for:
- 4 quarters
- Latest activity:
- 2021 Q3
According to 2026 Q2 report, Warren Buffett doesn't hold any Merck & Company Inc (MRK) shares. To date, the estimated cost basis is nearly $82.7 for "buy" trades and estimated average "sell" price is $77.51. Berkshire Hathaway first purchased MRK in 2020 Q3, initially acquiring about 22.40M shares. Since the initial investment in Merck & Company Inc (MRK), Berkshire Hathaway has made 4 more transactions.
When did Warren Buffett sell Merck & Company Inc (MRK)?
Warren Buffett sold off the entire Merck & Company Inc (MRK) position in 2021 Q3.
When did Warren Buffett buy Merck & Company Inc (MRK)?
Warren Buffett first invested in Merck & Company Inc (MRK) in 2020 Q3 at the reported quarter-end price of $82.95 per share.
What's the cost basis of Berkshire Hathaway's MRK stake?
The estimated cost basis for Merck & Company Inc (MRK) stake is around $82.70 per share. This represents their average reported price* across all buy transactions
Estimated cost basis*
- Weighted AVG buy price:
- $82.70
- Weighted AVG sell price:
- $77.51
Warren Buffett's historical trades in Merck & Company Inc
5 results
| Period |
% of portfolio |
Shares held after* |
Reported price* |
Value* |
% (shares) of activity |
% change to portfolio |
|---|---|---|---|---|---|---|
|
2021 Q3
|
0.00%
|
0
|
$77.77
|
|
-100% (-9,157,192)
|
-0.24%
|
|
2021 Q2
|
0.24%
|
9,157,192
|
$77.77
|
$712,155,000
|
-48.79% (-8,725,196)
|
-0.25%
|
|
2021 Q1
|
0.51%
|
17,882,388
|
$77.09
|
$1,378,553,000
|
-37.69% (-10,815,047)
|
-0.31%
|
|
2020 Q4
|
0.87%
|
$81.80
|
+28.10% (+6,294,333)
|
|||
|
2020 Q3
|
0.79%
|
$82.95
|
new
|
|||
* Shares, change to shares, sold shares, shares held after: split-adjusted.
* Reported price: this doesn't represent the actual buy or sell price. It is the split-adjusted price of the security as of the last day of the reported period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
* Estimated cost basis: based on "Reported price*" (not earlier than 2013 Q2). Calculation starts from the latest "new buy" activity to the latest "close out" activity (if any).
* Value or Price: If the security is completely sold out, we show the reported value (or price) prior to the actual period.
* New buy or own: this means there is no earlier reporting (for us or in general). So we can't know if the actual purchase of the security happened at the reported period or earlier.